Anna Laakmann, MD JD
@annalaakmann.bsky.social
Experienced biopharma executive who draws from both medical and legal training to provide solutions-oriented operational and strategic guidance on drug and diagnostic development and commercialization.
Thoughtful piece at The Timmerman Report on the wrenching decisions faced by people with cancer and the potential for the CARE Act to expand access to "concurrent care"...
timmermanreport.com/2024/11/what...
timmermanreport.com/2024/11/what...
November 27, 2024 at 7:33 PM
Thoughtful piece at The Timmerman Report on the wrenching decisions faced by people with cancer and the potential for the CARE Act to expand access to "concurrent care"...
timmermanreport.com/2024/11/what...
timmermanreport.com/2024/11/what...